MRNA tokenized / RWA perpetual funding rates — also called perpetual swap funding rates — are aggregated live by exchange across 26 venues on ORBIT. Funding is the recurring payment exchanged between long and short traders that keeps a perpetual swap tethered to the spot price — when it is positive, longs pay shorts; when negative, shorts pay longs. Right now MRNA funding ranges from -152.30% annualized on SoDEX to +10.96% on TxFlow.
The widest cross-exchange funding spread for MRNA is currently 163.3% APR. A delta-neutral funding trade captures this gap by going long on SoDEX — where funding is lowest, so the long leg is paid or pays the least — and short on TxFlow, where funding is highest, so the short leg collects. Because the two legs are equal and opposite, the asset's price moves cancel out and what is left is the funding spread. ORBIT's backtester replays the real funding history of both legs and subtracts live taker fees and order-book slippage, so the result is net PnL, not a headline number.
MRNA ranks #451 by open interest among tracked perpetual assets, total open interest across covered venues is $10.3M, 24h volume is $5.1M, the volume-weighted mark price is $196.8774. Deeper liquidity means a funding spread can be traded at larger size with lower slippage — use the Min OI filter on the screener to surface only markets you can realistically enter and exit.
Frequently asked questions
- Which exchange has the highest MRNA funding rate right now?
- TxFlow shows the highest MRNA funding at +10.96% annualized. A high positive rate means shorts get paid, so this is the venue to short MRNA when running a funding-arbitrage pair. Rates change every settlement window — check the live screener for the current value.
- Which exchange is best to long MRNA for funding?
- SoDEX has the lowest MRNA funding at -152.30% annualized, which makes the long leg cheapest (or paid). Pair it with the highest-funding venue to capture the spread delta-neutral.
- What is the best MRNA funding-arbitrage pair?
- The widest spread is long SoDEX / short TxFlow at about 163.3% APR before costs. Verify it in the ORBIT backtester, which subtracts real fees and slippage, before sizing a position.
- How often does MRNA funding settle?
- MRNA funding settles on different schedules by venue (1h, 8h). Longer intervals concentrate the same annualized rate into fewer, larger payments. ORBIT normalizes every venue to a common APR so they are directly comparable.
- Is MRNA funding positive or negative?
- MRNA funding is mixed across venues, ranging -152.30% to +10.96% APR — which is exactly what creates the cross-exchange arbitrage opportunity.
- What is the current MRNA perpetual swap funding rate?
- The current MRNA perpetual swap funding rate ranges from -152.30% to +10.96% annualized depending on the exchange — SoDEX is lowest and TxFlow is highest right now. There is no single MRNA funding rate: every venue runs its own funding formula and order book, which is why the rate has to be read by exchange rather than as one number.
- What is the aggregated MRNA funding rate across exchanges?
- Aggregated across the 26 venues ORBIT tracks, MRNA funding currently spans -152.30% to +10.96% APR, a spread of 163.3 percentage points. An aggregated average hides the part that matters for trading — the gap between the cheapest and dearest venue — so the table above lists each exchange separately.
- How do I read the MRNA 8h funding rate versus the annualized rate?
- Venues that settle MRNA every 8 hours quote the per-payment rate, which is charged three times a day. Multiply an 8h rate by 3 to get the daily figure and by 1,095 to annualize it. ORBIT converts every venue — 1h, 4h and 8h alike — to a common APR so an 8h rate and a 1h rate can be compared directly.